Form D · Other Health Care
Genomind, Inc.
King Of Prussia, PA · CIK 0001604902
Offering snapshot reported Apr 23, 2021 · SEC filing
- Reported sold
- $6.4M Offering amount: $21.2M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 24, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,900,000 → $6,400,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 23, 2021 | Amendment | $6,400,000 | $1,500,000vs Dec 9, 2020 | 8 | SEC filing |
| Dec 9, 2020 | Initial | $4,900,000 | No comparison | 8 | SEC filing |
| Sep 17, 2020 | Amendment | $20,575,000 | $16,100,000vs Dec 6, 2018 | 2 | SEC filing |
| Dec 6, 2018 | Amendment | $4,475,000 | $1,975,000vs Oct 2, 2018 | 2 | SEC filing |
| Oct 2, 2018 | Amendment | $2,500,000 | $1,000,000vs Aug 28, 2018 | 2 | SEC filing |
| Aug 28, 2018 | Amendment | $1,500,000 | $1,000,000vs Jul 13, 2018 | 2 | SEC filing |
| Jul 13, 2018 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Oct 24, 2017 | Amendment | $7,750,000 | $1,500,000vs Feb 14, 2017 | 5 | SEC filing |
| Feb 14, 2017 | Initial | $6,250,000 | No comparison | 5 | SEC filing |
| Jul 15, 2016 | Amendment | $20,950,000 | $3,000,000vs Apr 19, 2016 | 6 | SEC filing |
| Apr 19, 2016 | Amendment | $17,950,000 | $2,200,000vs Feb 8, 2016 | 6 | SEC filing |
| Feb 8, 2016 | Amendment | $15,750,000 | $2,000,000vs Dec 28, 2015 | 6 | SEC filing |
| Dec 28, 2015 | Amendment | $13,750,000 | $1,500,000vs Nov 6, 2015 | 6 | SEC filing |
| Nov 6, 2015 | Amendment | $12,250,000 | $2,500,000vs Jun 22, 2015 | 6 | SEC filing |
| Jun 22, 2015 | Amendment | $9,750,000 | $4,500,000vs Jan 30, 2015 | 6 | SEC filing |
| Jan 30, 2015 | Amendment | $5,250,000 | $3,000,000vs Apr 15, 2014 | 6 | SEC filing |
| Apr 15, 2014 | Initial | $2,250,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-382705
Series D Preferred Stock and Common Stock Purchase Warrants
Source: Form D, filed Apr 23, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Anton | Director |
| John Chadwick | Director |
| Ronald I. Dozoretz | Director, Executive, Promoter |
| Beth Dozoretz | Director |
| Stephen Haller | Executive |
| Thomas Hess | Executive |
| Tom Hess | Executive |
| Shelloy Kiger | Director |
| Michael Koffler | Director |
| Brad Lucas | Director |
| Gloria Nuss | Executive |
| Shawn Patrick O'brien | Director, Executive |
| Kip Olmstead | Executive |
| Theresa Sexton | Director |
| Scott Storrer | Executive, Promoter |
| Stacy Williams | Executive |
| Rina Wolf | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2200 Renaissance Boulevard, Suite 100
King Of Prussia, PA, 19406-2755
King Of Prussia, PA, 19406-2755